International Clinical Trial: The Role of TREM2 in Regulating Microglial Transition and Its Implications in Parkinson's Disease Pathogenesis

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132605) titled 'The Role of TREM2 in Regulating Microglial Transition and Its Implications in Parkinson's Disease Pathogenesis' on Sept. 16.

Study Type: Observational study

Study Design: Case-Control study

Primary Sponsor: The First Affiliated Hospital of Guangzhou Medical University

Condition: Parkinson's Disease Parkinson's Disease with Alzheimer's Disease Alzheimer's Disease

Intervention: Biospecimen Module-Healthy Control Group:None Handwriting Collection Module-Parkinson's Disease with Alzheimer's Disease Group (PD-AD Group):None Biospecimen Module-Parkinson's Disease Group (PD Group):None Handwriting Collection Mod...